Medicover sp. z o.o. Medicover Opieka Szpitalna Centrum Leczenia Chorób Serca i Naczyń Medicover

The medical center is at the forefront of research in nephrology and cardiac surgery, focusing on innovative approaches to prevent complications associated with these fields. The center's research is particularly concentrated on the prevention of cardiac surgery associated acute kidney injury (CSA-AKI), a significant concern for patients undergoing cardiac procedures.

• Prevention of CSA-AKI
• Reduction of Major Adverse Kidney Events (MAKE)
• Advanced therapeutic interventions

Through the study of ravulizumab, the center aims to reduce the risk of major adverse kidney events within 90 days post-surgery, thereby enhancing patient outcomes and advancing clinical practices in these critical areas.